Clinical Signs of Portal Hypertension
The key clinical signs of portal hypertension include ascites (most common), esophageal/gastric varices, splenomegaly with hypersplenism, and portal-systemic collaterals visible on imaging. 1, 2
Primary Clinical Manifestations
Ascites
- Most common complication in cirrhotic portal hypertension, developing in nearly 60% of patients within a decade of compensated cirrhosis diagnosis 1
- Represents decompensation and dramatically worsens prognosis from 80% to 50% five-year survival 1
- Can range from grade 1 (detectable only by ultrasound) to grade 3 (marked abdominal distension) 3
Varices
- Esophageal and gastric varices develop when hepatic venous pressure gradient (HVPG) reaches ≥10 mmHg (clinically significant portal hypertension) 1
- Gastroesophageal varices type 1 (GOV1) extend across the cardia into the lesser gastric curve
- Variceal bleeding is often the presenting manifestation, particularly in non-cirrhotic portal hypertension 2
Splenomegaly and Hypersplenism
- Enlarged spleen with associated cytopenias (anemia, leukopenia, thrombocytopenia) 2, 4
- Particularly prominent in idiopathic non-cirrhotic portal hypertension
- Platelet count <150,000/mm³ combined with other findings suggests clinically significant portal hypertension 5
Portal-Systemic Collaterals
- Visible on imaging as portosystemic shunts bypassing the liver 1
- Include paraumbilical veins, splenorenal shunts, and other collateral pathways
- Appearance of new collaterals during follow-up indicates worsening portal hypertension 5
Secondary Complications
Hepatorenal Syndrome (HRS)
- Frequent and grave complication triggered by splanchnic arterial vasodilation 1
- Type 1: progressive, severe renal decline
- Type 2: constant renal dysfunction, commonly with refractory ascites
Additional Signs
- Dilutional hyponatremia from circulatory dysfunction 1
- Spontaneous bacterial peritonitis in patients with ascites
- Hepatic encephalopathy in advanced cases
- Portal hypertensive gastropathy 2
Diagnostic Thresholds
Portal hypertension severity correlates with HVPG measurements 1:
- Normal: 1-5 mmHg
- Portal hypertension present: ≥6 mmHg
- Clinically significant portal hypertension (CSPH): ≥10 mmHg - when complications develop
- HVPG ≥16 mmHg: independently associated with higher mortality
Important Clinical Caveat
In primary sclerosing cholangitis (PSC), portal hypertension can occur with F2-F3 fibrosis before cirrhosis develops due to pre-sinusoidal obstruction from ductular proliferation and portal fibrosis 6. This explains why varices may appear with HVPG <10 mmHg in PSC, unlike typical cirrhotic portal hypertension. Similar pre-sinusoidal patterns occur in nodular regenerative hyperplasia and obliterative portal venopathy 6.
Non-Invasive Detection
When liver stiffness by transient elastography is <20 kPa AND platelet count >150,000/mm³, high-risk varices are very unlikely (<5% probability), potentially avoiding screening endoscopy 5. Progressive spleen enlargement on imaging surveillance for hepatocellular carcinoma should prompt evaluation for worsening portal hypertension 5.